Jan. 2021
Shanghai Lannacheng Biotechnology Co., Ltd. was established
Jun. 2022
LNC completed Series A financing
Jul. 2022
LNC was renamed "Yantai Lannacheng Biotechnology Co., Ltd." and moved to Yantai, Shandong
Aug. 2022
LNC Pharma Pte. Ltd., a Singapore subsidiary of LNC was established.
Jun. 2023
LNC completed Series B financing
Nov. 2023
The LNC research laboratory in Yantai MediPark was open
Apr. 2024
LNC completed Series B+ financing
Nov. 2024
LNC was renamed "Yantai Lannacheng Biotechnology Co., Ltd."